Article ID Journal Published Year Pages File Type
1179086 Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2008 8 Pages PDF
Abstract

The muscle nicotinic acetylcholine receptor (AChR) is the prototype of the ligand-gated ion channels (or Cys-loop receptors), formed by 5 homologous subunits (α2βγδ or α2βγɛ), and is the major autoantigen in the autoimmune disease, myasthenia gravis. Previously, we expressed the wild-type extracellular domain (ECD) of the γ-subunit (γECD) of the AChR in yeast Pichia pastoris at 0.3–0.8 mg/L, in soluble but microaggregate form, to use as starting material for structural and antigenicity studies. To optimize these characteristics, we constructed and characterized four γECD variants: (a) mutants-1 (γC61S) and -2 (γC106S-C115S), where the non-conserved Cys of γECD were replaced by serines, (b) mutant-3 (γCysLoop), where the γ Cys-loop region was substituted by the cognate region of the acetylcholine binding protein (AChBP) and (c) mutant-4 (γCysLoop-C106S-C115S), where both the C106S-C115S and Cys-loop mutations were combined. None of mutants-1 and -2 displayed any improvement, while mutant-3 and -4 were mostly in dimeric form and expressed at much higher levels (2.5 mg/L and 3.5 mg/L respectively). All four mutants and wild-type γECD were recognized by sera from myasthenic patients, but mutants-3 and -4 exhibited higher efficiency, compared to wild-type or mutants-1 and -2. These results suggest that the substitution of the Cys-loop region of any AChR ECD with the AChBP counterpart leads to AChR ECD of improved conformation, more suitable for structural and therapeutic studies.

Related Topics
Physical Sciences and Engineering Chemistry Analytical Chemistry
Authors
, , , ,